Point72 Hong Kong LTD Selecta Biosciences Inc Transaction History

Point72 Hong Kong LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.33 - $2.6 $2,951 - $5,769	2,219 New	2,219 $4,000
Q2 2022 Aug 15, 2022	SELL	$0.67 - $1.4 $12,751 - $26,644	-19,032 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.23 - $3.31 $16,703 - $44,949	13,580 Added 249.08%	19,032 $23,000
Q4 2021 Feb 14, 2022	SELL	$2.89 - $4.43 $835 - $1,280	-289 Reduced 5.03%	5,452 $18,000
Q3 2021 Nov 15, 2021	BUY	$3.36 - $4.62 $19,289 - $26,523	5,741 New	5,741 $24,000
Q1 2021 May 17, 2021	SELL	$2.92 - $5.07 $15,055 - $26,140	-5,156 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$1.64 - $3.42 $852 - $1,778	520 Added 11.22%	5,156 $16,000
Q3 2020 Nov 16, 2020	BUY	$2.18 - $2.84 $10,106 - $13,166	4,636 New	4,636 $11,000
Q1 2018 May 15, 2018	SELL	$8.49 - $11.82 $1,154 - $1,607	-136 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$8.97 - $23.38 $1,219 - $3,179	136	136 $1,000

4.67M

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.